acut
respiratori
infect
ari
caus
great
morbid
mortal
children
across
globe
ari
mainli
associ
viral
infect
gener
confin
upper
respiratori
tract
caus
cough
hoars
tregon
schwarz
howev
may
extend
lower
respiratori
tract
turn
caus
wheez
respiratori
distress
concomit
viral
bacteri
infect
caus
mainli
streptococcu
pneumonia
haemophilu
influenza
moraxella
catarrhali
lead
develop
acut
otiti
media
ruohola
et
al
pneumonia
nolan
et
al
add
anoth
layer
complex
microbi
interact
respiratori
tract
transcriptom
analys
provid
comprehens
effici
way
elucid
host
immun
respons
infecti
diseas
chaussabel
et
al
nakaya
et
al
vaccin
nakaya
et
al
recent
investig
use
blood
transcriptom
analysi
identifi
immun
signatur
communityacquir
pneumonia
cap
parnel
et
al
respiratori
syncyti
viru
rsv
infect
mejia
et
al
rhinoviru
rv
infect
heinonen
et
al
addit
analys
robust
enough
distinguish
bacteri
viral
respiratori
infect
suggest
transcript
profil
improv
diagnosi
suarez
et
al
sweeney
et
al
parallel
studi
perform
nasopharynx
interfac
shed
light
relationship
differ
microorgan
may
colon
site
pneumonia
h
influenza
caus
infect
rsv
rv
wiertsema
et
al
skevaki
et
al
uitti
et
al
previous
report
use
ncounter
technolog
identifi
viral
bacteri
agent
nasopharyng
aspir
npa
children
ari
enrol
refer
pediatr
emerg
unit
brazil
fukutani
et
al
present
studi
determin
microbi
viral
bacteri
load
perform
immun
transcript
profil
npa
children
ari
system
immunolog
approach
identifi
modular
commun
immun
respons
gene
correl
microbi
load
thu
distinguish
microberel
immun
signatur
legal
guardian
pediatr
patient
adult
particip
sign
written
term
inform
consent
studi
compli
guidelin
declar
helsinki
approv
institut
review
board
feder
univers
bahia
protocol
conduct
prospect
crosssect
studi
pediatr
emerg
room
feder
univers
bahia
hospit
salvador
northeastern
brazil
recruit
children
age
month
present
symptom
consist
ari
n
occur
septemb
octob
bouza
et
al
rna
extract
perform
random
subset
npa
n
correspond
total
cohort
children
ari
n
inclus
criteria
consist
report
fever
sneez
rhinorrhea
nasal
blockag
cough
day
exclus
criteria
transfer
anoth
hospit
report
previou
episod
wheez
pediatrician
perform
physic
examin
collect
data
use
standard
form
sampl
healthi
control
n
adult
recruit
conveni
inclus
criteria
consist
absenc
fever
cough
sore
throat
sneez
nasal
blockag
rhinorrhea
day
prior
absenc
nasal
medic
usag
nasopharyng
aspir
sampl
collect
enrol
subject
briefli
distanc
entranc
nostril
ear
lobe
use
estim
distanc
entranc
nostril
nasopharynx
asept
cathet
insert
nostril
upon
reach
nasopharynx
neg
pressur
appli
collect
approxim
ml
nasal
secret
sampl
place
steril
tube
contain
ml
nuclisen
lysi
buffer
biomerieux
frozen
use
healthi
control
n
collect
npa
perform
instil
ml
isoton
salin
nostril
follow
immedi
aspir
ml
via
insert
flexibl
cathet
sampl
transfer
steril
tube
contain
ml
nuclisen
lysi
buffer
biomerieux
frozen
use
total
ribonucl
acid
rna
obtain
use
rneasi
kit
qiagen
accord
manufactur
instruct
rna
quantifi
use
qubit
rna
hs
assay
invitrogen
hybrid
ng
customdesign
probe
use
ncounter
detect
follow
adenoviru
av
human
bocaviru
hbov
coronaviru
cov
rsv
b
influenza
viru
iv
b
parainfluenza
viru
piv
rv
human
metapneumoviru
hmpv
chlamydia
pneumonia
h
influenza
catarrhali
mycoplasma
pneumonia
pneumonia
fukutani
et
al
rna
also
hybrid
immun
target
use
immunolog
custom
set
probe
synthes
nanostr
ncounter
reaction
perform
nucleom
core
facil
vib
leuven
belgium
previous
describ
geiss
et
al
describ
fukutani
et
al
bouza
et
al
ncounter
probe
set
use
studi
extens
test
optim
semihigh
throughput
analysi
first
sensit
linear
absenc
crossreact
among
respiratori
bacteri
viral
target
test
panel
posit
control
obtain
collect
laboratori
clinic
virolog
ku
leuven
second
perform
pilot
experi
random
subset
sampl
cohort
n
due
financi
limit
pathogen
reliabl
detect
stage
use
subsequ
experi
nonetheless
confirm
detect
rsvarsvb
shown
ncounter
use
rtpcr
bouza
et
al
h
influenza
catarrhali
aureu
pneumonia
nextgener
sequenc
andrad
et
al
raw
data
preprocess
use
nsolver
softwar
nanostr
nanostringnorm
r
packag
waggott
et
al
describ
fukutani
et
al
standard
protocol
sequenti
correct
two
factor
individu
sampl
technic
variat
sampl
use
spike
posit
control
rna
background
correct
use
spike
neg
control
rna
method
allow
identif
multipl
pathogen
npa
sampl
ari
patient
singl
reaction
present
low
rna
yield
ng
fukutani
et
al
pathogen
transcript
count
transform
individu
microbi
load
determin
compar
number
transcript
individu
cutoff
valu
establish
mean
plu
three
standard
deviat
eight
intern
neg
control
reaction
npa
microbi
count
respect
cutoff
consid
pathogenposit
npa
microbi
count
calcul
cutoff
consid
indetermin
supplementari
dataset
npa
consid
posit
classifi
bacteri
viral
codetect
ie
present
viral
bacteri
transcript
identifi
relationship
node
bacteria
viru
present
npa
construct
associ
matrix
use
gephi
network
distribut
creat
use
forc
atla
algorithm
fukutani
et
al
immun
respons
transcript
quantifi
describ
earlier
microbi
pathogen
except
transform
differenti
express
immun
transcript
deit
determin
multipl
ttest
employ
benjaminihochberg
correct
fals
discoveri
rate
fdr
set
full
list
gene
shown
supplementari
dataset
deit
determin
compar
transcript
ari
patient
healthi
control
pathway
enrich
deit
perform
use
gene
set
enrich
analysi
gsea
subramanian
et
al
gsea
run
prerank
individu
gene
valu
gene
analyz
use
reactom
databas
nomin
p
permut
fabregat
et
al
correl
deit
spearman
p
npa
microbi
load
determin
use
r
r
core
team
correl
strength
assess
nonparametr
bootstrap
replic
valu
consid
modular
analysi
blondel
et
al
perform
identifi
node
dens
interconnect
supplementari
dataset
deit
significantli
correl
microbi
load
present
bootstrap
resampl
consid
commun
wherea
deit
threshold
mark
bystand
spars
partial
least
squar
spl
approach
implement
r
packag
liquet
et
al
deit
use
predictor
microbi
load
respons
variabl
method
disintegr
predictor
respons
variat
identifi
correl
contributor
variat
compon
spl
score
use
spearman
correl
analysi
bacteri
viral
load
confirm
role
correl
deit
addit
deit
also
determin
compar
npa
ari
patient
classifi
microbi
load
bacteri
viral
codetect
ari
patient
classifi
indetermin
cellspecif
gene
list
valid
cten
cell
type
enrich
shoemak
et
al
use
identifi
enrich
cell
type
immun
signatur
observ
comparison
correl
modular
analys
also
perform
respect
deit
supplementari
dataset
deriv
evolutionarili
conserv
antivir
score
use
genomewid
crossspeci
comparison
type
ifninduc
antivir
respons
talli
number
speci
signific
fdr
antivir
activ
individu
gene
shaw
et
al
prospect
studi
random
npa
sampl
correspond
complet
cohort
n
children
diagnos
ari
initi
determin
microbi
load
npa
use
customdesign
probe
ncounter
digit
transcriptom
npa
evalu
sampl
show
microbi
transcript
count
calcul
cutoff
consid
posit
npa
classifi
bacteri
n
viral
n
codetect
present
bacteri
viral
transcript
n
figur
supplementari
dataset
five
npa
classifi
indetermin
microbi
transcript
count
calcul
cutoff
thu
display
microbi
profil
similar
healthi
control
figur
supplementari
dataset
among
bacteri
npa
present
h
influenza
transcript
figur
transcript
pneumonia
npa
catarrhali
npa
pneumonia
c
pneumonia
npa
also
detect
figur
supplementari
dataset
viral
npa
detect
transcript
rsva
rsva
iva
hmpv
rsvb
figur
supplementari
dataset
transcript
cov
ivb
detect
npa
evalu
codetect
npa
h
influenza
transcript
also
overtli
repres
npa
figur
b
supplementari
dataset
occur
combin
transcript
rsva
rsvb
hmpv
upon
examin
correl
among
differ
microbi
target
npa
figur
h
influenza
center
network
indic
associ
target
detect
particularli
pneumonia
catarrhali
viral
target
associ
mostli
bacteri
target
rare
anoth
viral
target
eg
rv
bov
baselin
demograph
clinic
characterist
studi
group
describ
tabl
mean
age
patient
ari
month
femal
frequent
complaint
coryza
cough
sneez
upon
physic
examin
frequent
find
fever
wheez
notabl
observ
signific
differ
either
verbal
complaint
find
follow
physic
examin
children
harbor
npa
classifi
bacteri
viral
codetect
tabl
therefor
cohort
ari
symptom
could
associ
specif
respiratori
pathogen
pathogen
class
viral
vs
bacteri
data
shown
note
strict
viral
presenc
observ
npa
aureu
transcript
detect
similar
number
across
npa
examin
henc
includ
analysi
pathogenrel
immun
signatur
supplementari
figur
follow
determin
microbi
load
nasopharyng
interfac
comprehens
explor
immun
signatur
also
transcriptom
profil
use
larg
panel
prespecifi
immun
responserel
gene
initi
exploratori
analysi
deit
determin
compar
npa
children
ari
npa
healthi
control
supplementari
figur
bacteri
npa
display
upregul
gene
figur
wherea
gene
upregul
viral
npa
figur
codetect
npa
show
highest
number
upregul
immun
gene
n
figur
mention
previous
five
npa
classifi
indetermin
microbi
transcript
count
establish
cutoff
indistinguish
healthi
control
sampl
also
display
upregul
gene
n
figur
use
gsea
bacteri
npa
show
broadest
enrich
pathway
wherea
viral
npa
expectedli
relat
antivir
immun
interferon
activ
supplementari
figur
bacteri
viral
codetect
npa
enrich
type
type
ii
interferon
signal
next
use
modular
analysi
identifi
deit
dens
connect
togeth
correl
microbi
load
among
deit
upregul
bacteri
npa
shown
figur
deit
form
modulecommun
directli
correl
bacteri
load
figur
wherea
remain
gene
form
separ
modulecommun
supplementari
dataset
contrari
among
deit
detect
viral
npa
shown
figur
modulecommun
correl
viral
load
consist
gene
figur
codetect
npa
present
highest
number
upregul
gene
communitymodul
correl
microbi
presenc
contain
five
gene
notabl
gene
encod
protein
involv
complement
activ
differenti
express
correl
bacteri
load
bacteri
codetect
npa
wherea
chemokin
recruit
activ
cell
neutrophil
monocyt
correl
microbi
load
viral
codetect
npa
figur
therefor
situ
transcriptom
reveal
three
communitiesmodul
first
modul
consist
depict
modul
plu
immun
gene
whose
express
directli
correl
bacteri
count
figur
herein
mostli
h
influenza
shown
figur
second
modular
commun
consist
gene
depict
modul
plu
gene
figur
whose
express
directli
correl
viral
count
rsv
piv
av
etc
last
commun
consist
five
gene
whose
express
correl
bacteri
viral
transcript
codetect
npa
appli
spl
regress
confirm
modulescommun
immun
gene
identifi
previous
correl
microbi
load
step
bacteri
codetect
npa
analyz
togeth
sinc
present
transcript
bacteria
viral
codetect
npa
sinc
present
viral
transcript
inde
observ
strong
posit
correl
r
p
figur
bacteri
modul
immun
gene
shown
figur
bacteri
load
result
also
obtain
r
p
figur
compar
viral
modul
immun
gene
shown
figur
thu
identifi
situ
gene
signatur
specif
attribut
quantiti
bacteri
andor
viral
transcript
npa
children
ari
shown
figur
subset
npa
classifi
indetermin
sinc
microbi
transcript
count
establish
cutoff
similar
healthi
control
despit
clinic
symptom
shown
children
therefor
perform
new
set
analys
compar
two
group
npa
children
symptom
detect
microbi
load
viral
bacteri
codetect
vs
children
symptom
microbi
load
cutoff
indetermin
hypothes
gene
express
profil
detect
ncounter
could
distinguish
microbi
presenc
independ
clinic
symptom
thu
appli
analysi
pipelin
supplementari
figur
identifi
whether
immun
signatur
bacteri
viral
codetect
npa
distinct
present
indetermin
npa
notabl
number
deit
bacteri
n
figur
viral
n
figur
codetect
npa
n
figur
lower
comparison
indetermin
npa
comparison
healthi
control
shown
figur
bacteri
viral
npa
gene
downregul
figur
b
respect
suggest
indetermin
npa
display
stronger
modul
immun
respons
importantli
adapt
immun
transcript
appear
discrimin
viral
bacteri
codetect
npa
compar
indetermin
npa
exampl
prototyp
b
cell
transcript
hladob
predomin
viral
npa
figur
use
cten
curat
list
cell
typespecif
gene
found
b
cell
transcript
significantli
enrich
among
viral
deit
enrich
p
bacteri
npa
myeloid
marco
coinhibitori
transcript
tigit
detect
figur
significantli
correl
bacteri
load
accord
cten
classif
monocyt
btk
myeloidspecif
marco
gene
significantli
enrich
among
bacteri
deit
p
strikingli
express
codetect
viral
npa
figur
agreement
uniqu
protect
role
respiratori
virus
review
andreako
et
al
transcript
factor
maf
detect
comparison
suggest
univers
express
npa
present
detect
microbi
load
compar
npa
present
undetect
microbi
load
indetermin
similar
previou
comparison
perform
healthi
control
shown
figur
identifi
two
modulescommun
immun
gene
associ
either
bacteri
viral
load
figur
latter
modul
consist
modulecommun
immun
gene
associ
bacteri
presenc
posit
correl
microbi
load
r
p
figur
result
indic
bacteri
npa
display
situ
immun
signatur
specif
also
differ
observ
indetermin
npa
lastli
focus
bacteri
npa
compar
modulecommun
immun
gene
detect
comparison
healthi
control
npa
shown
figur
vs
detect
comparison
indetermin
npa
shown
figur
thu
identifi
immun
gene
specif
express
children
symptomat
ari
harbor
bacteri
viral
transcript
nasopharyng
interfac
figur
also
identifi
anoth
set
immun
gene
uniqu
express
symptomat
children
ari
microbi
detect
establish
threshold
indetermin
intersect
two
modul
establish
subset
eight
immun
gene
express
condit
irrespect
type
microbi
presenc
presenc
clinic
symptom
figur
group
gene
consist
bona
fide
myeloid
marker
marco
costimulatori
transcript
also
coinhibitori
molecul
btk
btla
slam
accessori
protein
may
repres
gener
nasopharyng
immun
signatur
ari
despit
global
impact
ari
understand
immun
respons
occur
nasopharyng
interfac
still
incomplet
herein
character
immun
respons
npa
interfac
symptomat
children
ari
display
microbi
load
consist
bacteri
viral
combin
immun
respons
microbi
load
determin
use
situ
transcriptom
enabl
us
identifi
modular
commun
gene
express
respons
bacteri
viral
presenc
nasopharyng
aspir
initi
character
classifi
accord
microbi
transcript
present
major
sampl
harbor
either
strictli
bacteri
composit
bacteri
viral
transcript
codetect
minor
display
presenc
viral
transcript
among
bacteria
h
influenza
predomin
bacterium
togeth
pneumonia
catarrhali
make
healthi
nasopharynx
microbiom
bogaert
et
al
viral
presenc
occur
mostli
presenc
bacteria
common
transcript
rsv
b
rsv
one
common
etiolog
agent
respiratori
infect
includ
pneumonia
nascimentocarvalho
et
al
haemophilu
influenza
compon
healthi
upper
respiratori
tract
microbiota
bogaert
et
al
spread
caus
system
local
infect
colon
h
influenza
begin
infanc
approxim
case
colon
within
first
year
life
howard
et
al
new
bacteri
viral
acquisit
occur
potenti
disturb
microenviron
lead
invas
dissemin
complic
exampl
rv
infect
stimul
pneumonia
adhes
airway
epitheli
cell
ishizuka
et
al
wherea
rsv
infect
increas
express
receptor
pathogen
bacteria
avadhanula
et
al
two
possibl
mechanist
explan
complic
diseas
simultan
bacterialvir
infect
also
shown
pleural
effus
complic
pneumonia
shown
occur
children
mix
viral
bacteri
presenc
nascimentocarvalho
et
al
although
analys
confirm
presenc
microbi
transcript
npa
includ
number
sampl
mix
codetect
transcript
clinic
symptom
present
children
differ
significantli
harbor
singl
infect
least
time
admiss
regard
viral
ari
increas
diseas
sever
case
multipl
codetect
clinic
observ
review
nascimentocarvalho
ruuskanen
howev
report
review
therein
employ
dna
detect
may
reflect
rang
condit
differ
strategi
employ
mrna
detect
thu
mirror
activ
viral
bacteri
replic
follow
classif
npa
accord
microbi
load
sought
determin
immun
signatur
nasopharyng
interfac
gene
express
immun
responserel
gene
compar
npa
obtain
children
ari
vs
npa
obtain
healthi
control
overal
detect
strong
upregul
gene
express
strongest
npa
classifi
codetect
follow
bacteri
viral
npa
classifi
indetermin
also
display
clinic
symptom
signific
upregul
gene
express
might
explain
two
hypothes
mutual
exclus
first
hypothesi
indetermin
npa
might
contain
unknown
respiratori
nonrespiratori
pathogen
present
custom
set
probe
contain
respiratori
virus
bacteria
current
consid
clinic
relev
second
hypothesi
indetermin
immun
signatur
might
trigger
environment
allergen
agreement
recent
observ
environment
factor
presenc
dog
bird
hous
associ
wheez
children
ari
oliveira
et
al
submit
furthermor
ncounter
proven
highli
sensit
detect
retro
viral
transcript
cell
line
moen
et
al
equal
sensit
realtim
pcr
detect
rsva
rsvb
npa
bouza
et
al
submit
argu
failur
ncounter
technolog
detect
microbi
transcript
indetermin
npa
function
analysi
differenti
express
gene
point
common
pathway
enrich
across
npa
classif
interferon
alpha
beta
gamma
signal
type
interferon
alphabeta
produc
earli
upon
viru
infect
signal
though
ifnar
receptor
induc
gene
encod
protein
import
limit
viral
replic
type
ii
interferon
gamma
produc
lymphocyt
nk
cell
associ
inflammatori
respons
mejia
et
al
also
found
interferonsign
pathway
upregul
pathway
blood
transcriptom
analysi
cohort
children
rsv
infect
studi
author
follow
patient
rsv
infect
found
greater
activ
interferonrel
gene
followup
suggest
rsv
downregul
interferonrel
respons
mejia
et
al
interferon
pathway
also
upregul
blood
transcriptom
individu
ari
caus
presenc
viru
zhai
et
al
given
distinct
presenc
bacteri
viral
codetect
transcript
npa
sought
determin
whether
specif
immun
signatur
could
identifi
group
thu
correl
express
immun
gene
microbi
load
perform
modular
analysi
enabl
us
identifi
modular
commun
gene
express
respons
bacteri
presenc
viral
presenc
codetect
bacteri
modular
commun
contain
gene
associ
varieti
function
includ
chemokin
transcript
factor
cytokin
gene
relat
tnf
protein
inhibit
classic
pathway
complement
activ
subsequ
opson
follow
lysi
correl
bacteri
load
well
bacteri
plu
viral
codetect
load
bind
sever
bacteri
pathogen
includ
h
influenza
hallstrom
et
al
catarrhali
nordstrom
et
al
enhanc
bacteri
adhes
exampl
among
gene
posit
correl
viral
load
two
interferonregul
chemokin
togeth
bind
receptor
preferenti
attract
activ
nk
cell
recent
evid
point
toward
nonredund
role
three
ifninduc
ligand
vivo
exampl
viral
infect
allerg
reaction
review
metzemaek
et
al
find
line
result
children
ari
moreov
comparison
gene
observ
codetect
modular
commun
gene
present
viral
modular
commun
display
significantli
higher
evolutionari
antivir
score
supplementari
figur
result
base
upon
genomewid
crossspeci
comparison
type
ifninduc
antivir
respons
shaw
et
al
underscor
biolog
link
viral
gene
modul
viral
load
ari
also
compar
immun
respons
npa
clearli
detect
microbi
load
bacteri
viral
codetect
classifi
indetermin
comparison
viral
codetect
npa
indetermin
npa
show
uniqu
share
two
clinic
group
significantli
correl
viral
load
type
iii
ifn
induc
varieti
isg
interf
viral
replic
sadler
william
seem
major
sourc
ifn
airway
epitheli
cell
khaitov
et
al
express
respons
rsv
spann
et
al
iv
durbin
et
al
present
npa
sampl
also
perform
addit
analysi
ten
postari
sampl
larger
cohort
children
collect
week
recruit
diagnosi
sampl
subject
ncounter
analysi
compar
sampl
detect
pathogen
bacteri
viral
codetect
group
total
viral
load
decreas
normal
count
almost
fortyfold
cure
patient
week
followup
data
shown
result
statist
signific
p
due
low
number
high
coeffici
variat
hand
bacteri
load
remain
equal
high
normal
count
cure
postari
sampl
sampl
ari
acut
phase
also
found
roughli
fivefold
decreas
transcript
median
iqr
iqr
normal
count
p
regard
transcript
although
decreas
still
correl
posit
viral
r
p
bacteri
load
r
p
postari
sampl
trend
observ
type
ifn
transcript
either
p
bacteri
viral
load
therefor
result
emphas
hypothesi
type
iii
ifn
might
play
protect
role
ongo
antivir
possibl
antivir
immun
respons
possibl
antibacteri
immun
respons
nasal
mucosa
even
outsid
symptomat
phase
ari
pediatr
patient
small
size
short
followup
week
ari
diagnosi
find
remain
confirm
larger
cohort
prolong
clinic
microbiolog
followup
comparison
viral
codetect
npa
indetermin
npa
show
modul
contrari
comparison
made
npa
healthi
individu
observ
suggest
repres
marker
ari
type
iii
ifn
induc
varieti
isg
interfer
viral
replic
sadler
william
seem
major
sourc
ifn
airway
epitheli
cell
khaitov
et
al
express
respons
rsv
spann
et
al
iv
durbin
et
al
present
npa
sampl
moreov
maf
modul
bacteri
viral
codetect
comparison
indetermin
npa
protein
cmaf
encod
maf
gene
dnabind
leucin
zippercontain
transcript
factor
depend
bind
site
bind
partner
transcript
activ
repressor
play
role
regul
sever
cellular
process
protein
cmaf
one
transcript
factor
signal
develop
follicular
helper
cell
tfh
cell
andri
et
al
develop
requir
sequenti
step
involv
cytokin
surfac
receptor
transcript
factor
signal
tfh
cell
critic
humor
respons
activ
b
cell
class
switch
germin
center
format
jogdand
et
al
result
suggest
maf
may
key
regul
immun
respons
ari
regardless
type
microbi
presenc
final
compar
immun
gene
modul
comparison
npa
healthi
individu
vs
npa
classifi
indetermin
figur
identifi
three
categori
gene
immun
gene
specif
presenc
microbi
load
immun
gene
specif
presenc
clinic
symptom
group
gene
intersect
two
set
propos
latter
group
may
act
marker
immun
respons
nasopharyng
interfac
children
ari
importantli
marco
scaveng
receptor
express
tissueresid
macrophag
recogn
variou
bacteri
pathogen
marco
exampl
enhanc
adenoviru
infect
maler
et
al
hand
receptor
major
monocytemacrophag
growth
factor
mcsf
gmcsf
respect
thu
monocytesmacrophag
may
provid
bridg
innat
adapt
immun
nasal
mucosa
ari
cluster
lymphocyt
activ
marker
ikaro
encod
central
kinas
lymphokin
signal
hand
presenc
myeloid
marker
marco
costimulatori
molecul
coinhibitori
molecul
slam
accessori
protein
observ
bacteri
npa
parallel
presenc
coinhibitori
molecul
encod
gene
preferenti
express
treg
exhaust
marker
encod
gene
inhibitori
fc
receptor
contain
itim
motif
known
dampen
local
immun
respons
studi
crosssect
design
infer
tempor
causal
deleteri
protect
immun
signatur
robust
correl
bacteri
viral
load
togeth
document
antivir
immunomodulatori
role
review
andreako
et
al
suggest
pivot
role
type
iii
ifn
maintain
tissu
homeostasi
ari
due
crosssect
design
studi
ethic
limit
unabl
sampl
healthi
agematch
infant
inher
limit
studi
initi
exploratori
analysi
compar
npa
children
ari
vs
npa
healthi
adult
howev
studi
suffici
power
reveal
distinct
immun
signatur
link
specif
viral
vs
bacteri
pathogen
symptomat
children
second
part
studi
thu
identifi
uniqu
situ
immun
signatur
bacteri
viral
presenc
npa
help
elucid
factor
contribut
ari
pediatr
patient
lead
identif
candid
molecul
futur
immunotherapeut
immunoprophylact
intervent
analyz
dataset
studi
includ
manuscript
supplementari
file
kf
jvw
design
experi
kf
perform
experi
analys
cnc
mb
jo
collect
sampl
ab
td
rk
jvw
hn
contribut
analysi
kf
cnc
jvw
ba
co
wrote
manuscript
author
read
approv
final
manuscript
author
declar
research
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
